Traws Pharma Files Amended Proxy Statement
Ticker: TRAW · Form: DEF 14A · Filed: Aug 9, 2024 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | DEF 14A |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.01, $25,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: TRAW
TL;DR
Traws Pharma (TRAW) filed its DEF 14A, annual meeting Sept 16. Vote your shares!
AI Summary
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed an amended DEF 14A proxy statement on August 9, 2024, for its annual meeting on September 16, 2024. The company, incorporated in Delaware and headquartered in Newtown, PA, operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with essential information regarding the company's annual meeting, including proposals to be voted on and details about director nominations, which are crucial for corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently introduce new financial risks.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- 20240809 (date) — Filing date
- 20240916 (date) — Annual meeting date
- 267-759-3680 (phone_number) — Business phone
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit shareholder votes for its annual meeting or other matters requiring shareholder approval.
When is Traws Pharma, Inc.'s annual meeting scheduled?
The annual meeting for Traws Pharma, Inc. is scheduled for September 16, 2024.
What was Traws Pharma, Inc. formerly known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
Where is Traws Pharma, Inc. headquartered?
Traws Pharma, Inc. is headquartered at 12 Penns Trail, Newtown, PA 18940.
What is the SEC file number for Traws Pharma, Inc.?
The SEC file number for Traws Pharma, Inc. is 001-36020.
Filing Stats: 4,843 words · 19 min read · ~16 pages · Grade level 11 · Accepted 2024-08-09 06:00:52
Key Financial Figures
- $0.01 — f the Company's common stock, par value $0.01 per share ("Common Stock"), upon conver
- $25,000 — on, we have retained Innisfree at a fee $25,000, plus certain out-of-pocket expenses, t
Filing Documents
- tm2418367-4_def14a.htm (DEF 14A) — 1058KB
- lg_hcwainwright-4clr.jpg (GRAPHIC) — 8KB
- lg_trawspharma-4clr.jpg (GRAPHIC) — 12KB
- px_24trawsproxy1pg01-bw.jpg (GRAPHIC) — 220KB
- px_24trawsproxy1pg02-bw.jpg (GRAPHIC) — 173KB
- sg_hcwainwright-bw.jpg (GRAPHIC) — 5KB
- 0001104659-24-087458.txt ( ) — 1576KB
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 56 WHERE YOU CAN FIND ADDITIONAL INFORMATION 58 HOUSEHOLDING 59 INFORMATION INCORPORATED BY REFERENCE 59 OTHER MATTERS 60 Annex A CERTIFICATE OF AMENDMENT TO TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TRAWS PHARMA, INC. A-1 Annex B CERTIFICATE OF AMENDMENT TO TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TRAWS PHARMA, INC. B-1 Annex C OPINION OF H.C. WAINRIGHT & CO. LLC C-1 i TABLE OF CONTENTS Traws Pharma, Inc. Traws Pharma, INC. 12 Penns Trail Newtown, PA 18940 (267) 759-3680 PROXY STATEMENT SPECIAL MEETING OF STOCKHOLDERS To Be Held on September 16, 2024 INFORMATION CONCERNING SOLICITATION AND VOTING This proxy statement contains information about the Special Meeting of Stockholders of Traws Pharma, Inc. (the "Special Meeting"), which will be held virtually, via live webcast at www.virtualshareholdermeeting.com/TRAW2024SM on September 16, 2024 at 9:00 a.m. Eastern Time. The board of directors of Traws Pharma, Inc. (the "Board of Directors") is using this proxy statement to solicit proxies for use at the Special Meeting. In this proxy statement, the terms "Traws", "Traws Pharma", "the Company," "we," "us," and "our" refer to Traws Pharma, Inc. References to "Onconova" refer specifically to the Company prior to April 1, 2024. The mailing address of our principal executive offices is Traws Pharma, Inc., 12 Penns Trail, Newtown, PA 18940. All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our Board of Directors with respect to each of the matters set forth in the accompanying Notice of Meeting. You may revoke your proxy at any time before it is exercised at the meeting by giving our corporate secretary written notice to that effect. At the Special Meeting: 1. Traws will ask its stockholders